Obesity Facts and Information

Orexigen obesity drug shows added benefits

Nearly half of patients who completed 56 weeks of treatment with Orexigen Therapeutics Inc’s experimental obesity treatment, Contrave, lost at least 10 percent of their weight in a late-stage study and the drug also appeared to help cholesterol and blood sugar levels. The drug demonstrated an even greater improvement in non- weight loss measures in [...]

Continue reading...